article thumbnail

The Healthcare and Macro-Economic Impacts of Living with Endemic COVID – Listening to Fitch

Health Populi

While telehealth and virtual care stood up quickly in 2020, questions remain about how it will/can persist in terms of funding, regulation, and business models. We also expect innovation to come out of pharma and biotech labs, and who will pay for new-new therapies?

BioTech 270
article thumbnail

Let’s Save the Date and Make Patient Engagement Official in 2022

Society for Participatory Medicine

Healthcare stakeholders such as health systems, pharmaceutical companies, biotech and life sciences firms, and insurance companies serve patients as end users. Market forces drove acceleration in digital health, specifically telemedicine, which were sorely needed for several years. Connect with her at [link]. Did you enjoy this post?

BioTech 107
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Pharma’s Future Relevance Depends on Empathy, Messaging, Partnering, and Supporting Patients and Providers

Health Populi

This new work-flow for clinicians led to fast-adoption of virtual care platforms – telemedicine, tele-conferencing with patients via apps like Zoom and Skype along with commercially-built telehealth channels, and the prescription and use of remote health monitoring devices placed in patients’ homes.

article thumbnail

Value-Based Health Care Needs All Stakeholders at the Table – Especially the Patient

Health Populi

Speaking of design, this Summit was indeed well-designed by spotlighting pragmatic representatives from these various stakeholder groups.

article thumbnail

As COVID-19 Rocks Markets, Digital Health Start-Ups Rake In Cash

Lloyd Price

One leading sector of the digital health space, telemedicine companies, generated three times the amount of financing they received in Q1 2019, raising $788 million in venture capital backing, compared to $220 million in the first quarter of 2019. " Health start-ups look singularly poised to weather the coronavirus storm.

article thumbnail

Prescription Drugs in the Pandemic, Year 2: Pricing Rx and Going Direct-to-Consumer

Health Populi

Integrating with the telehealth service Care on the Optum Store. This last aspect is taking a strategic page out of the playbooks of Hims, Nurx, Ro, Truepill and other DTC-facing prescription drug + telehealth services that have proliferated in the U.S. There is one health care public policy issue that unites U.S.